Illumina (ILMN) is a publicly traded Healthcare sector company. As of August 14, 2026, ILMN trades at $193.02 with a market cap of $29.13B and a P/E ratio of 35.66. ILMN moved +0.19% today. Year to date, ILMN is +43.39%; over the trailing twelve months it is +90.53%. Its 52-week range spans $68.70 to $207.00. Analyst consensus is buy with an average price target of $192.44. Rallies surfaces ILMN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Illumina (ILMN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ILMN moved +0.19% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $193.02 |
| Market Cap | $29.13B |
| P/E Ratio | 35.66 |
| EPS | $5.39 |
| Dividend Yield | 0.00% |
| 52-Week High | $207.00 |
| 52-Week Low | $68.70 |
| Volume | 264 |
| Avg Volume | 0 |
| Revenue (TTM) | $4.49B |
| Net Income | $824.00M |
| Gross Margin | 66.38% |
16 analysts cover ILMN: 0 strong buy, 8 buy, 5 hold, 3 sell, 0 strong sell. Consensus rating is buy. Average price target: $192.44.